Mr. Charles Gore

Charles Gore was diagnosed with hepatitis C in 1995 and cirrhosis in 1998. Troubled by his inability to find clear, accurate and unbiased information and by the lack of any organisation providing support in the UK, in 2000 he set up The Hepatitis C Trust with 3 other hepatitis C patients, and took on the role of running it. In 2002 he did pegylated interferon and ribavirin treatment and successfully eradicated the virus.

Charles Gore has worked extensively with Government Departments and the National Health Service in the UK, championing the patient perspective. He was on the selection board for the National Clinical Director for Liver Disease and is currently co-chairing the pathways, systems and levers workstream of the National Liver Disease Strategy.

He was closely involved in the creation of the European Liver Patients Association and was elected its first President in 2004, promoting the cause of hepatitis B and hepatitis C at European level. In 2007 he organised a meeting of hepatitis patient organisations from around the world to agree on co-ordinated global action. From this emerged the decision to hold an annual World Hepatitis Day and to create a new NGO, the World Hepatitis Alliance, of which Charles was the President between 2007 and 2017.

Charles Gore is currently the Executive Director of The Medicines Patent Pool (MPP) Governance Board in Geneva, Switzerland.